Sale by Carl Dambkowski (Chief Medical Officer)
5,500 shares · @ $84.14 · $462,784
Apogee Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $79.30
-5.7% in 7d after detection
Post-detection moves
1h
—
1d
+1.9%
3d
+1.1%
7d
-5.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS